FDA.reportPublic FDA data

vigabatrin 500 MG Oral Tablet [Vigadrone]

RxCUI
2642353
RxNorm name
vigabatrin 500 MG Oral Tablet [Vigadrone]
Display name
vigabatrin 500 MG Oral Tablet [Vigadrone]
Full name
vigabatrin 500 MG Oral Tablet [Vigadrone]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VIGADRONEVIGABATRINUpsher-Smith Laboratories, LLC01f7f049-78c2-47c2-a66e-ec662ba48a982024-11-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2642353

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
01f7f049-78c2-47c2-a66e-ec662ba48a98VIGADRONE 500 MG Oral Tablet [PSN] · vigabatrin 500 MG Oral Tablet [Vigadrone] [SBD] · Vigadrone 500 MG Oral Tablet [SY]32These highlights do not include all the information needed to use VIGADRONE ® TABLETS safely and effectively. See full prescribing information for VIGADRONE ® TABLETS. VIGADRONE ® (vigabatrin) tablets, for oral use Initial U.S. Approval: 200920241118